CD20 + FCRL4 + B Cells Activate CD8 + T Cells via MHC‐I Restriction in Nasopharyngeal Carcinoma Anti‐Tumor Immunity
Advanced Science · 2026
DOI: 10.1002/advs.202514982 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Benjian Zhang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital of Central South University, Changsha, P. R. China. Hauptthemen laut MEDLINE: Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, CD8-Positive T-Lymphocytes, B-Lymphocytes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Central South University Graduate Students Independent Exploration and Innovation Project, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Nasopharyngeal carcinoma (NPC) is a malignant tumor characterized by extensive immune cell infiltration. However, the function and significance of B cells in NPC have been overlooked. Exploring B cells and their interactions with other immune cells will provide deeper insights into the immune microenvironment of NPC and theories of immunotherapy.We utilized single‐cell sequencing data to identify characteristic B cell subtypes of NPC. Subsequently, the presence of the CD20 + FCRL4 + B cell subpopulation was validated in NPC samples using immunohistochemistry and flow cytometry. The interaction between this B cell subpopulation and CD8 + T cells was investigated by establishing an in vitro and in vivo co‐culture system.Our analysis revealed a subset of CD20 + FCRL4 + B cells that may interact with CD8 + T cells through the MHC‐I pathway. Furthermore, we observed a co‐localized distribution of CD20 + FCRL4 + B cells and CD8 + T cells in NPC. Additionally, in vitro experiments demonstrated that IFNγ played a pivotal role in enhancing the delivery of MHC class I‐restricted epitope peptides by B cells, potentially due to the upregulation of WDFY4. B cells pre‐stimulated with HK‐1 lysate and IFNγ, when co‐cultured with T cells, can induce the proliferation of CD8 + T cells and the formation of immunological memory. Ultimately, this process mediates the cytotoxicity of CD8 + T cells against tumor cells both in vitro and in vivo. Notably, we found a positive correlation between the infiltration level of CD20 + FCRL4 + B cells and the expression of PD‐1, as well as the response to anti‐PD‐1 therapy or gemcitabine plus cisplatin combined with anti‐PD‐1 therapy in NPC.Overall, our study elucidates the potential anti‐tumor mechanisms of CD20 + FCRL4 + B cells and provides insights into their role in immunotherapy for NPC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital of Central South University, Changsha, P. R. China.
- Hunan Province Key Laboratory of Otolaryngology Critical Diseases, Xiangya Hospital of Central South University, Changsha, P. R. China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital of Central South University, Changsha, P. R. China.
- Anatomy Laboratory of Division of Nose and Cranial Base, Clinical Anatomy Center of Xiangya Hospital, Central South University, Changsha, P. R. China.
- Department Of Head and Neck Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
- Institute of Otolaryngology Head and Neck Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu, P. R. China.
ORCID-Profile: Weihong Jiang
Förderung
- National Natural Science Foundation of China
- Central South University Graduate Students Independent Exploration and Innovation Project
- Natural Science Foundation of Hunan Province
Zitieren
APA
Zhang, B., Yuan, X., Gao, K., You, B., Wang, Y., Meng, L., Chen, Z., Xie, S., Liu, Y., Dong, Z., Xie, S., Fan, R., Wang, F., Zhang, J., Xie, Z., Mo, Y., Zhang, H., & Jiang, W. (2026). CD20 + FCRL4 + B Cells Activate CD8 + T Cells via MHC‐I Restriction in Nasopharyngeal Carcinoma Anti‐Tumor Immunity. Advanced Science. https://doi.org/10.1002/advs.202514982
Vancouver
Zhang B, Yuan X, Gao K, You B, Wang Y, Meng L, et al. CD20 + FCRL4 + B Cells Activate CD8 + T Cells via MHC‐I Restriction in Nasopharyngeal Carcinoma Anti‐Tumor Immunity. Advanced Science. 2026. doi:10.1002/advs.202514982
BibTeX
@article{Zhang2026,
author = {Zhang, Benjian and Yuan, Xiaotian and Gao, Kelei and You, Bo and Wang, Yaxuan and Meng, Lai and Chen, Zirong and Xie, Shaobing and Liu, Yunqing and Dong, Zijian and Xie, Shumin and Fan, Ruohao and Wang, Fengjun and Zhang, Junyi and Xie, Zhihai and Mo, Yongzhen and Zhang, Hua and Jiang, Weihong},
title = {CD20 + FCRL4 + B Cells Activate CD8 + T Cells via MHC‐I Restriction in Nasopharyngeal Carcinoma Anti‐Tumor Immunity},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202514982}
}
EUVIMED